Boysie1985
Active Member
- Messages
- 32
- Type of diabetes
- Type 1
- Treatment type
- Pump
You may want to look at some of the other products that AT now sell and used to be free to answer that question...I would just like clarity on what is happening. Are there other incurred costs to the UK distributers or are we being taken advantage of? If it's the latter then it simply isn't acceptable to be making money off of our conditions.
It's perfectly acceptable and it's the very reason why so many treatment options exist and why new options are being developed.I would just like clarity on what is happening. Are there other incurred costs to the UK distributers or are we being taken advantage of? If it's the latter then it simply isn't acceptable to be making money off of our conditions.
You've missed the point - nobody is complaining about the prices Dexcom charge and it's agreed they need to make money (and, as you point out, that profit will in many cases be used to develop exciting new treatment options). However, it's another matter when an independent third-party distributor -- who is not a pharma company and does not develop or have any interest in the R&D process -- rips-off customers with exorbitant pricing by way of exploiting their monopoly position.It's perfectly acceptable and it's the very reason why so many treatment options exist and why new options are being developed.
It's unrealistic to think that pharmaceutical companies are in business solely to help people. They're in business to make money.
Money allows for more research which leads to new treatments which ultimately leads to a cure.
That's an extremely rude and unfounded statement to make.You've missed the point - nobody is complaining about the prices Dexcom charge and it's agreed they need to make money (and, as you point out, that profit will in many cases be used to develop exciting new treatment options). However, it's another matter when an independent third-party distributor -- who is not a pharma company and does not develop or have any interest in the R&D process -- rips-off customers with exorbitant pricing by way of exploiting their monopoly position.
If the process upsets you then perhaps you should deal with Dexcom directly?You've missed the point - nobody is complaining about the prices Dexcom charge and it's agreed they need to make money (and, as you point out, that profit will in many cases be used to develop exciting new treatment options). However, it's another matter when an independent third-party distributor -- who is not a pharma company and does not develop or have any interest in the R&D process -- rips-off customers with exorbitant pricing by way of exploiting their monopoly position.
One can certainly question the pricing structure in the UK when pricing in other European countries is clearly displayed and obviously 25% cheaper...That's an extremely rude and unfounded statement to make.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?